[Latest information on the treatment of uterine cervical cancer].
We investigated the role of hemoglobin level in chemoradiation therapy for patients with advanced cervical cancer by reviewing the literature for current therapeutic information. We found that anemia during chemoradiation therapy is an important physiological factor in determining the long-term prognosis of patients with advanced cervical cancer.
Watanabe
Yoh
Y
Department of Obstetrics and Gynecology, Kinki University School of Medicine, 377-2 Ohno-Higashi, Osakasayama, Osaka 589-8511, Japan.
Ueda
Haruhiko
H
D015687:Cell Hypoxia; D002986:Clinical Trials as Topic; D004921:Erythropoietin / Q000627:therapeutic use; D005260:Female; D006454:Hemoglobins / Q000032:analysis*; D006801:Humans; D011379:Prognosis; D011994:Recombinant Proteins; D002583:Uterine Cervical Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000532:radiotherapy*
D006454:Hemoglobins; D011994:Recombinant Proteins; D004921:Erythropoietin